Product Code: ETC9963879 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United States (US) DNA Repair Drugs Market Overview |
3.1 United States (US) Country Macro Economic Indicators |
3.2 United States (US) DNA Repair Drugs Market Revenues & Volume, 2021 & 2031F |
3.3 United States (US) DNA Repair Drugs Market - Industry Life Cycle |
3.4 United States (US) DNA Repair Drugs Market - Porter's Five Forces |
3.5 United States (US) DNA Repair Drugs Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.6 United States (US) DNA Repair Drugs Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 United States (US) DNA Repair Drugs Market Revenues & Volume Share, By Dosage Form, 2021 & 2031F |
3.8 United States (US) DNA Repair Drugs Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 United States (US) DNA Repair Drugs Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing incidence of cancer and other genetic disorders requiring DNA repair drugs |
4.2.2 Advancements in DNA repair drug research and development |
4.2.3 Rising investments in precision medicine and personalized treatments |
4.3 Market Restraints |
4.3.1 Stringent regulatory approval processes for DNA repair drugs |
4.3.2 High costs associated with research, development, and production of DNA repair drugs |
4.3.3 Limited awareness and adoption of DNA repair drugs among healthcare professionals and patients |
5 United States (US) DNA Repair Drugs Market Trends |
6 United States (US) DNA Repair Drugs Market, By Types |
6.1 United States (US) DNA Repair Drugs Market, By Drug Type |
6.1.1 Overview and Analysis |
6.1.2 United States (US) DNA Repair Drugs Market Revenues & Volume, By Drug Type, 2021- 2031F |
6.1.3 United States (US) DNA Repair Drugs Market Revenues & Volume, By PARP Inhibitors, 2021- 2031F |
6.1.4 United States (US) DNA Repair Drugs Market Revenues & Volume, By Alkylating Agents, 2021- 2031F |
6.1.5 United States (US) DNA Repair Drugs Market Revenues & Volume, By Others, 2021- 2031F |
6.2 United States (US) DNA Repair Drugs Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 United States (US) DNA Repair Drugs Market Revenues & Volume, By Breast Cancer, 2021- 2031F |
6.2.3 United States (US) DNA Repair Drugs Market Revenues & Volume, By Ovarian Cancer, 2021- 2031F |
6.2.4 United States (US) DNA Repair Drugs Market Revenues & Volume, By Lung Cancer, 2021- 2031F |
6.2.5 United States (US) DNA Repair Drugs Market Revenues & Volume, By Head and Neck Cancer, 2021- 2031F |
6.2.6 United States (US) DNA Repair Drugs Market Revenues & Volume, By Others, 2021- 2031F |
6.3 United States (US) DNA Repair Drugs Market, By Dosage Form |
6.3.1 Overview and Analysis |
6.3.2 United States (US) DNA Repair Drugs Market Revenues & Volume, By Tablets, 2021- 2031F |
6.3.3 United States (US) DNA Repair Drugs Market Revenues & Volume, By Capsules, 2021- 2031F |
6.3.4 United States (US) DNA Repair Drugs Market Revenues & Volume, By Injectables, 2021- 2031F |
6.4 United States (US) DNA Repair Drugs Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 United States (US) DNA Repair Drugs Market Revenues & Volume, By Retail Pharmacies, 2021- 2031F |
6.4.3 United States (US) DNA Repair Drugs Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F |
6.4.4 United States (US) DNA Repair Drugs Market Revenues & Volume, By Online Pharmacies, 2021- 2031F |
7 United States (US) DNA Repair Drugs Market Import-Export Trade Statistics |
7.1 United States (US) DNA Repair Drugs Market Export to Major Countries |
7.2 United States (US) DNA Repair Drugs Market Imports from Major Countries |
8 United States (US) DNA Repair Drugs Market Key Performance Indicators |
8.1 Number of clinical trials for DNA repair drugs in the US |
8.2 Research and development expenditure in the DNA repair drugs market |
8.3 Adoption rate of precision medicine practices in oncology and genetic disorders in the US |
8.4 Number of partnerships and collaborations between pharmaceutical companies and research institutions for DNA repair drug development |
8.5 Patient outcomes and survival rates post-treatment with DNA repair drugs |
9 United States (US) DNA Repair Drugs Market - Opportunity Assessment |
9.1 United States (US) DNA Repair Drugs Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.2 United States (US) DNA Repair Drugs Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 United States (US) DNA Repair Drugs Market Opportunity Assessment, By Dosage Form, 2021 & 2031F |
9.4 United States (US) DNA Repair Drugs Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 United States (US) DNA Repair Drugs Market - Competitive Landscape |
10.1 United States (US) DNA Repair Drugs Market Revenue Share, By Companies, 2024 |
10.2 United States (US) DNA Repair Drugs Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |